+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Lactoferrin Market Size, Share & Trends Analysis Report by Function (Iron Absorption, Anti-inflammatory, Intestinal Flora Protection, Antibacterial), by Application, by Region, and Segment Forecasts, 2020 - 2027

  • ID: 4330247
  • Report
  • March 2020
  • Region: Global
  • 125 pages
  • Grand View Research
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • APS BioGroup
  • Farbest Brands
  • Glanbia PLC
  • InVitria
  • Milligans Food Group
  • Pharming Group NV
  • MORE
The global lactoferrin market size is projected to reach USD 379.5 million by 2027, registering a revenue-based CAGR of 8.1% over the forecast period. Increasing incorporation of lactoferrin in various products ranges including infant food, food supplements, dietetic foods, alcoholic beverages, sports nutrition, and personal care and cosmetics should bolster lactoferrin market in the forecast timeframe, ascribed to strong health benefits.

Lactoferrin offers stimulating effects on immune system, prevents cell damage caused by aging, promotes culture of beneficial bacterial in the intestinal tract, and regulates viruses, bacteria and fungi along with being regulator to iron metabolism. Lactoferrin is found effective for the treatment of hepatitis C infection by inhibiting replication of the virus at intracellular level. Hence, strong applicability of lactoferrin in nutraceutical, pharmaceutical, and personal care industries is anticipated to drive demand during the forecast period.

Human colostrum has the highest lactoferrin concentration, followed by human milk and then by bovine milk. It is also readily found in human body secretions including nose, eyes, intestine, and respiratory tract. Lactoferrin can be used as a conjuncture of specific strains of friendly bacteria, together they are proven to boost immune function of the body, alert the white blood cells of the harmful microbes, and to stabilize colonies of gut friendly bacteria. Commercially, lactoferrin is commonly integrated with probiotics to achieve this.

Asia Pacific is expected to expand at a CAGR of over 7.5% during the forecast period. The lactoferrin market is projected to witness strong rise in demand, as the key market players continue adopting strategies to expand its presence in untapped economies of South East Asia. Countries including China, Japan, and Australia have experienced high awareness regarding the health benefits of lactoferrin, which is expected to bolster regional growth over the forecast period.

Further key findings from the report suggest:
  • In terms of functions offered by lactoferrin, iron absorption segment accounted for the largest market share of over 29.0% in terms of revenue in 2019. This growth is expected to be supported by the growing incidences of iron deficiency and related disorders like anemia
  • Lactoferrin helps in restricting growth of acne due to its antioxidant properties. It helps combat free radicals formed due to natural process of oxidation. These free radicals can damage the cells and tissues promoting inflammation and acne. Such factors are expected to drive the product demand in personal care and cosmetics
  • Increasing investment in research, new product development, expansion of operation in developing nations, partnerships and collaboration with local players, and acquisition of small and medium sized players are among the major operational strategies taken up by key participants to strengthen and sustain their market positions

Please note: This product will be delivered within 48 business hours after receipt of order.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • APS BioGroup
  • Farbest Brands
  • Glanbia PLC
  • InVitria
  • Milligans Food Group
  • Pharming Group NV
  • MORE
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. Internal database
1.3.3. Secondary Sources & Third-Party Perspectives
1.3.4. Primary Research
1.4. Information Analysis
1.4.1. Data Analysis Models
1.5. Market Formulation & Data Visualization
1.6. Data Validation & Publishing

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segmental Outlook
2.3. Competitive Insights

Chapter 3. Lactoferrin Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Lactoferrin Market Size & Growth Prospects, 2016 - 2027
3.3. Industry Value Chain Analysis
3.3.1. Major Raw Material Trends
3.3.2. Manufacturing Trends/Technology Trends
3.3.3. List of Key End-Users, by Region
3.4. Sales Channel Trends
3.5. Regulatory Framework
3.6. Lactoferrin Market - Market dynamics
3.6.1. Market driver Analysis
3.6.2. Market Restraint Analysis
3.6.3. Industry Challenges
3.7. Business Environment Analysis: Lactoferrin Market
3.7.1. Industry Analysis - Porter’s
3.7.1.1. Supplier Power
3.7.1.2. Buyer Power
3.7.1.3. Substitution Threat
3.7.1.4. Threat from New Entrant
3.7.1.5. Competitive Rivalry
3.7.2. PESTEL Analysis
3.7.2.1. Political Landscape
3.7.2.2. Environmental Landscape
3.7.2.3. Social Landscape
3.7.2.4. Technology Landscape
3.7.2.5. Economic Landscape
3.7.2.6. Legal Landscape
3.7.3. Major Deals & Strategic Alliances Analysis
3.7.3.1. Joint Ventures
3.7.3.2. Mergers & Acquisitions

Chapter 4. Lactoferrin Market: Function Estimates & Trend Analysis
4.1. Lactoferrin Market: Function movement analysis, 2019 & 2027
4.2. Iron Absorption
4.2.1. Market estimates and forecasts, 2016 - 2027 (Tons) (USD Thousand)
4.3. Anti-Inflammatory
4.3.1. Market estimates and forecasts, 2016 - 2027 (Tons) (USD Thousand)
4.4. Intestine Flora Protection
4.4.1. Market estimates and forecasts, 2016 - 2027 (Tons) (USD Thousand)
4.5. Antibacterial
4.5.1. Market estimates and forecasts, 2016 - 2027 (Tons) (USD Thousand)
4.6. Immune Cell Stimulation
4.6.1. Market estimates and forecasts, 2016 - 2027 (Tons) (USD Thousand)
4.7. Antioxidant
4.7.1. Market estimates and forecasts, 2016 - 2027 (Tons) (USD Thousand)

Chapter 5. Lactoferrin Market: Application Estimates & Trend Analysis
5.1. Lactoferrin Market: Application movement analysis, 2019 & 2027
5.2. Food & Beverages
5.2.1. Market estimates and forecasts, 2016 - 2027 (Tons) (USD Thousand)
5.3. Infant Formula
5.3.1. Market estimates and forecasts, 2016 - 2027 (Tons) (USD Thousand)
5.4. Sports & Functional Food
5.4.1. Market estimates and forecasts, 2016 - 2027 (Tons) (USD Thousand)
5.5. Pharmaceuticals
5.5.1. Market estimates and forecasts, 2016 - 2027 (Tons) (USD Thousand)
5.6. Personal Care Products
5.6.1. Market estimates and forecasts, 2016 - 2027 (Tons) (USD Thousand)
5.7. Others
5.7.1. Market estimates and forecasts, 2016 - 2027 (Tons) (USD Thousand)

Chapter 6. Lactoferrin Market: Regional Estimates & Trend Analysis
6.1. Lactoferrin Market: Regional movement analysis, 2019 & 2027
6.2. North America
6.2.1. Market Estimates and Forecasts, 2016 - 2027 (Tons) (USD Thousand)
6.2.2. Market Estimates and Forecasts, By Function, 2016 - 2027 (Tons) (USD Thousand)
6.2.3. Market Estimates and Forecasts, By Application, 2016 - 2027 (Tons) (USD Thousand)
6.2.4. U.S.
6.2.4.1. Market Estimates and Forecasts, 2016 - 2027 (Tons) (USD Thousand)
6.2.4.2. Market Estimates and Forecasts, By Function, 2016 - 2027 (Tons) (USD Thousand)
6.2.4.3. Market Estimates and Forecasts, By Application, 2016 - 2027 (Tons) (USD Thousand)
6.2.5. Canada
6.2.5.1. Market Estimates and Forecasts, 2016 - 2027 (Tons) (USD Thousand)
6.2.5.2. Market Estimates and Forecasts, By Function, 2016 - 2027 (Tons) (USD Thousand)
6.2.5.3. Market Estimates and Forecasts, By Application, 2016 - 2027 (Tons) (USD Thousand)
6.2.6. Mexico
6.2.6.1. Market Estimates and Forecasts, 2016 - 2027 (Tons) (USD Thousand)
6.2.6.2. Market Estimates and Forecasts, By Function, 2016 - 2027 (Tons) (USD Thousand)
6.2.6.3. Market Estimates and Forecasts, By Application, 2016 - 2027 (Tons) (USD Thousand)
6.3. Europe
6.3.1. Market Estimates and Forecasts, 2016 - 2027 (Tons) (USD Thousand)
6.3.2. Market Estimates and Forecasts, By Function, 2016 - 2027 (Tons) (USD Thousand)
6.3.3. Market Estimates and Forecasts, By Application, 2016 - 2027 (Tons) (USD Thousand)
6.3.4. Germany
6.3.4.1. Market Estimates and Forecasts, 2016 - 2027 (Tons) (USD Thousand)
6.3.4.2. Market Estimates and Forecasts, By Function, 2016 - 2027 (Tons) (USD Thousand)
6.3.4.3. Market Estimates and Forecasts, By Application, 2016 - 2027 (Tons) (USD Thousand)
6.3.5. U.K.
6.3.5.1. Market Estimates and Forecasts, 2016 - 2027 (Tons) (USD Thousand)
6.3.5.2. Market Estimates and Forecasts, By Function, 2016 - 2027 (Tons) (USD Thousand)
6.3.5.3. Market Estimates and Forecasts, By Application, 2016 - 2027 (Tons) (USD Thousand)
6.3.6. France
6.3.6.1. Market Estimates and Forecasts, 2016 - 2027 (Tons) (USD Thousand)
6.3.6.2. Market Estimates and Forecasts, By Function, 2016 - 2027 (Tons) (USD Thousand)
6.3.6.3. Market Estimates and Forecasts, By Application, 2016 - 2027 (Tons) (USD Thousand)
6.4. Asia Pacific
6.4.1. Market Estimates and Forecasts, 2016 - 2027 (Tons) (USD Thousand)
6.4.2. Market Estimates and Forecasts, By Function, 2016 - 2027 (Tons) (USD Thousand)
6.4.3. Market Estimates and Forecasts, By Application, 2016 - 2027 (Tons) (USD Thousand)
6.4.4. China
6.4.4.1. Market Estimates and Forecasts, 2016 - 2027 (Tons) (USD Thousand)
6.4.4.2. Market Estimates and Forecasts, By Function, 2016 - 2027 (Tons) (USD Thousand)
6.4.4.3. Market Estimates and Forecasts, By Application, 2016 - 2027 (Tons) (USD Thousand)
6.4.5. India
6.4.5.1. Market Estimates and Forecasts, 2016 - 2027 (Tons) (USD Thousand)
6.4.5.2. Market Estimates and Forecasts, By Function, 2016 - 2027 (Tons) (USD Thousand)
6.4.5.3. Market Estimates and Forecasts, By Application, 2016 - 2027 (Tons) (USD Thousand)
6.4.6. Japan
6.4.6.1. Market Estimates and Forecasts, 2016 - 2027 (Tons) (USD Thousand)
6.4.6.2. Market Estimates and Forecasts, By Function, 2016 - 2027 (Tons) (USD Thousand)
6.4.6.3. Market Estimates and Forecasts, By Application, 2016 - 2027 (Tons) (USD Thousand)
6.4.7. Australia
6.4.7.1. Market Estimates and Forecasts, 2016 - 2027 (Tons) (USD Thousand)
6.4.7.2. Market Estimates and Forecasts, By Function, 2016 - 2027 (Tons) (USD Thousand)
6.4.7.3. Market Estimates and Forecasts, By Application, 2016 - 2027 (Tons) (USD Thousand)
6.5. Central & South America
6.5.1. Market Estimates and Forecasts, 2016 - 2027 (Tons) (USD Thousand)
6.5.2. Market Estimates and Forecasts, By Function, 2016 - 2027 (Tons) (USD Thousand)
6.5.3. Market Estimates and Forecasts, By Application, 2016 - 2027 (Tons) (USD Thousand)
6.5.4. Brazil
6.5.4.1. Market Estimates and Forecasts, 2016 - 2027 (Tons) (USD Thousand)
6.5.4.2. Market Estimates and Forecasts, By Function, 2016 - 2027 (Tons) (USD Thousand)
6.5.4.3. Market Estimates and Forecasts, By Application, 2016 - 2027 (Tons) (USD Thousand)
6.6. Middle East & Africa
6.6.1. Market Estimates and Forecasts, 2016 - 2027 (Tons) (USD Thousand)
6.6.2. Market Estimates and Forecasts, By Function, 2016 - 2027 (Tons) (USD Thousand)
6.6.3. Market Estimates and Forecasts, By Application, 2016 - 2027 (Tons) (USD Thousand)
6.6.4. UAE
6.6.4.1. Market Estimates and Forecasts, 2016 - 2027 (Tons) (USD Thousand)
6.6.4.2. Market Estimates and Forecasts, By Function, 2016 - 2027 (Tons) (USD Thousand)
6.6.4.3. Market Estimates and Forecasts, By Application, 2016 - 2027 (Tons) (USD Thousand)

Chapter 7. Lactoferrin Market: Competitive Analysis
7.1. Key Global Players, Their Initiatives, & Their Impact on the Market
7.2. Key Company/Competition Categorization (Key Innovators, Market Leaders, Emerging Players)
7.3. Vendor Landscape
7.3.1. List of key distributors & channel partners
7.3.2. Key customers
7.3.3. Company ranking, 2019
7.4. Public Companies
7.4.1. Company market position analysis
7.4.2. Company ranking, 2019
7.4.3. SWOT analysis
7.5. Private Companies
7.5.1. List of key emerging companies/technology disruptors/innovators
7.5.2. Geographical presence
7.5.3. Company market position analysis

Chapter 8. Company Profiles
8.1. Metagenics, Inc.
8.1.1. Company Overview
8.1.2. Financial Performance
8.1.3. Product Benchmarking
8.1.4. Strategic Initiatives
8.2. Pharming Group NV
8.2.1. Company Overview
8.2.2. Financial Performance
8.2.3. Product Benchmarking
8.2.4. Strategic Initiatives
8.3. Westland Cooperative Dairy Co., Ltd
8.3.1. Company Overview
8.3.2. Financial Performance
8.3.3. Product Benchmarking
8.3.4. Strategic Initiatives
8.4. Synlait Milk Ltd.
8.4.1. Company Overview
8.4.2. Financial Performance
8.4.3. Product Benchmarking
8.4.4. Strategic Initiatives
8.5. Ingredia SA
8.5.1. Company Overview
8.5.2. Financial Performance
8.5.3. Product Benchmarking
8.5.4. Strategic Initiatives
8.6. MP Biomedicals
8.6.1. Company Overview
8.6.2. Financial Performance
8.6.3. Product Benchmarking
8.6.4. Strategic Initiatives
8.7. Tatura Milk Industries Ltd
8.7.1. Company Overview
8.7.2. Financial Performance
8.7.3. Product Benchmarking
8.7.4. Strategic Initiatives
8.8. Glanbia PLC
8.8.1. Company Overview
8.8.2. Financial Performance
8.8.3. Product Benchmarking
8.8.4. Strategic Initiatives
8.9. APS BioGroup
8.9.1. Company Overview
8.9.2. Financial Performance
8.9.3. Product Benchmarking
8.9.4. Strategic Initiatives
8.10. ProHealth
8.10.1. Company Overview
8.10.2. Financial Performance
8.10.3. Product Benchmarking
8.10.4. Strategic Initiatives
8.11. Fonterra Cooperative Group Ltd.
8.11.1. Company Overview
8.11.2. Financial Performance
8.11.3. Product Benchmarking
8.11.4. Strategic Initiatives
8.12. Farbest Brands
8.12.1. Company Overview
8.12.2. Financial Performance
8.12.3. Product Benchmarking
8.12.4. Strategic Initiatives
8.13. InVitria
8.13.1. Company Overview
8.13.2. Financial Performance
8.13.3. Product Benchmarking
8.13.4. Strategic Initiatives
8.14. Milei GmbH
8.14.1. Company Overview
8.14.2. Financial Performance
8.14.3. Product Benchmarking
8.14.4. Strategic Initiatives
8.15. Ferrin-Tech LLC
8.15.1. Company Overview
8.15.2. Financial Performance
8.15.3. Product Benchmarking
8.15.4. Strategic Initiatives
8.16. Bega Cheese Limited
8.16.1. Company Overview
8.16.2. Financial Performance
8.16.3. Product Benchmarking
8.16.4. Strategic Initiatives
8.17. Warrnambool Cheese and Butter Company
8.17.1. Company Overview
8.17.2. Financial Performance
8.17.3. Product Benchmarking
8.17.4. Strategic Initiatives
8.18. Hoogwegt Group B.V.
8.18.1. Company Overview
8.18.2. Financial Performance
8.18.3. Product Benchmarking
8.18.4. Strategic Initiatives
8.19. Xi'an Oriherb Bio-Tech Co., Ltd.
8.19.1. Company Overview
8.19.2. Financial Performance
8.19.3. Product Benchmarking
8.19.4. Strategic Initiatives
8.20. Hefei Joye Import & Export Co., Ltd.
8.20.1. Company Overview
8.20.2. Financial Performance
8.20.3. Product Benchmarking
8.20.4. Strategic Initiatives
8.21. ND Pharma & Biotech Ltd.
8.21.1. Company Overview
8.21.2. Financial Performance
8.21.3. Product Benchmarking
8.21.4. Strategic Initiatives
8.22. FrieslandCampina
8.22.1. Company Overview
8.22.2. Financial Performance
8.22.3. Product Benchmarking
8.22.4. Strategic Initiatives
8.23. BioQuad Lifesciences
8.23.1. Company Overview
8.23.2. Financial Performance
8.23.3. Product Benchmarking
8.23.4. Strategic Initiatives
8.24. Milligans Food Group
8.24.1. Company Overview
8.24.2. Financial Performance
8.24.3. Product Benchmarking
8.24.4. Strategic Initiatives
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Metagenics, Inc.
  • Pharming Group NV
  • Westland Cooperative Dairy Co., Ltd
  • Synlait Milk Ltd.
  • Ingredia SA
  • MP Biomedicals
  • Tatura Milk Industries Ltd
  • Glanbia PLC
  • APS BioGroup
  • ProHealth
  • Fonterra Cooperative Group Ltd.
  • Farbest Brands
  • InVitria
  • Milei GmbH
  • Ferrin-Tech LLC
  • Bega Cheese Limited
  • Warrnambool Cheese and Butter Company
  • Hoogwegt Group B.V.
  • Xi'an Oriherb Bio-Tech Co., Ltd.
  • Hefei Joye Import & Export Co., Ltd.
  • ND Pharma & Biotech Ltd.
  • FrieslandCampina
  • BioQuad Lifesciences
  • Milligans Food Group
Note: Product cover images may vary from those shown
Adroll
adroll